Furthermore, it has been revealed that cell cyle factors such as cyclin D1 and cyclin B1 was downregulated by ZFX knockdown in multiple cancer types [17, 19, 20], which might account for the cell cycle disruption in Tca-8113 cells treated with ZFX-siRNA. The gene discussed is CCND1; the disease is cancer.